Indivior PLC (LON:INDV – Get Free Report) passed below its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of GBX 1,238 and traded as low as GBX 1,230. Indivior shares last traded at GBX 1,238, with a volume of 8,457,898 shares traded.
Indivior Price Performance
The company has a market capitalization of £1.93 billion, a price-to-earnings ratio of -1,026.48, a price-to-earnings-growth ratio of -5.57 and a beta of 0.19. The business has a 50-day moving average price of GBX 1,238 and a 200-day moving average price of GBX 1,238. The company has a quick ratio of 1.52, a current ratio of 0.90 and a debt-to-equity ratio of -141.86.
Indivior Company Profile
Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose. Its core marketed products include SUBLOCADE and SUBUTEX PRO buprenorphine extended-release monthly injections; SUBOXONE, a buprenorphine and naloxone sublingual film; SUBOXONE, a buprenorphine and naloxone sublingual tablet; and SUBUTEX, a buprenorphine sublingual tablet for the treatment of opioid use disorder.
Featured Stories
- Five stocks we like better than Indivior
- The gold chart Wall Street is terrified of…
- What a Former CIA Agent Knows About the Coming Collapse
- Elon Musk already made me a “wealthy man”
- Unlocked: Elon Musk’s Next Big IPO
- 1,500 Banks Just Handed the Fed Your Bank Account
Receive News & Ratings for Indivior Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Indivior and related companies with MarketBeat.com's FREE daily email newsletter.
